gsk
aims
stop
aids
profiteers
one
worlds
largest
manufacturers
hivaids
drugs
launched
initiative
combat
smuggling
cheaper
pills
supplied
poorer
african
countries
back
europe
resale
far
higher
price
company
glaxosmithkline
alter
packaging
change
colour
pills
currently
provided
developing
nations
humanitarian
agreement
estimated
drugs
companies
losing
hundreds
millions
dollars
year
result
diversion
products
way
sensitive
area
big
drugs
companies
want
maintain
profits
put
tremendous
pressure
provide
cheap
antiaids
drugs
worlds
poorest
nations
result
drugs
supplied
africa
thirty
times
cheaper
sold
europe
bringing
medicines
within
reach
millions
hivpositive
africans
governments
health
care
systems
wide
difference
price
also
means
big
gains
made
illegally
diverting
cheaper
drugs
back
wealthier
countries
reselling
higher
price
glaxosmithkline
believes
coating
pills
destined
africa
red
dye
adding
new
identification
codes
onto
pills
packaging
trade
substantially
reduced
company
says
possible
identify
specific
distributors
africa
resold
humanitarian
drugs
profit
well
suppliers
europe
also
involved
trade
glaxo
says
distribution
newlook
drugs
already
begun
chemical
content
identical
currently
sold
europe
